Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.

Radium exposure causes severe health issues, so strict safety measures are essential.

The excimer lamp is a safe and effective treatment for severe alopecia areata.

Abietic acid from pine resin can effectively inhibit testosterone 5α-reductase.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Referral rates for anaphylaxis patients improved significantly after implementing guidelines.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Horse alopecia areata is rare and mainly affects their appearance.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Dermatologists should consider congenital syndromes like TRPS in young adults with early hair loss.

PRP shows promise for improving hair growth in early to moderate hair loss but needs standardized methods for consistent results.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

PRF is promising for dental and aesthetic uses but needs more research.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

A new classification and scoring system is needed for alopecia areata to better assess severity.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

PRP shows promise for hair growth but needs standardized methods for better results.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

The treatment was not recommended due to limited effectiveness and significant side effects.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

The NIPAL4 mutation c.527C>A is common in Romanian patients with autosomal recessive congenital ichthyosis.

Two specific genetic markers increase the risk of hair loss in Asian populations.